Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Link Pharma chem Ltd has informed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Ltd has informed BSE that a Board of Directors meeting is scheduled for Saturday, 14th February 2026. The Board will, among other things, consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2025. The company's trading window for designated persons is already closed since 1st January 2026 and will reopen 48 hours after the results are declared. The intimation is issued under Regulation 29 of SEBI LODR Regulations, 2015.
This is a routine regulatory intimation ahead of the Q3 FY26 results announcement. Investors should watch for the actual results on 14th February 2026 to assess the company's performance. The closed trading window means insiders cannot trade until 48 hours post-results, which is standard compliance practice.